Our story
Founded in 1999, PHSE has focused since its inception on the logistical management of clinical trials, later specialising in active temperature-controlled shipping (Active Cool Chain) for pharmaceuticals, biotech, biological samples and clinical trials serving the hospital, home care and clinical research channels. In 2020, the entry of Eddy De Vita into the corporate structure, at 70%, supported by the investment fund NB Aurora, marks an important step in the development of PHSE’s international platform, which counts 6 acquisitions between 2021 and 2024, four of whitch abroad ( UK, India, Brazil, Germany) and two in Italy.
Today, PHSE is trusted by leading companies around the world to manage their time critical and temperature sensitive logistics needs.